The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study

[1]  T. Hickish,et al.  Glucose Intolerance During Adjuvant Chemotherapy for Breast Cancer , 2016 .

[2]  S. Groshen,et al.  A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan. , 2015, Cell metabolism.

[3]  G. Giaccone,et al.  A Phase I/II Trial of Belinostat in Combination with Cisplatin, Doxorubicin, and Cyclophosphamide in Thymic Epithelial Tumors: A Clinical and Translational Study , 2014, Clinical Cancer Research.

[4]  H. Putter,et al.  Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01). , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  Mark P Mattson,et al.  Fasting: molecular mechanisms and clinical applications. , 2014, Cell metabolism.

[6]  F. Ghetti,et al.  Kinetics of nuclear phosphorylation (γ-H2AX) in human lymphocytes treated in vitro with UVB, bleomycin and mitomycin C. , 2013, Mutagenesis.

[7]  C. Du,et al.  Correlation of dynamic changes in γ-H2AX expression in peripheral blood lymphocytes from head and neck cancer patients with radiation-induced oral mucositis , 2013, Radiation Oncology.

[8]  H. Pijl,et al.  Effects of prolonged fasting on AMPK signaling, gene expression, and mitochondrial respiratory chain content in skeletal muscle from lean and obese individuals. , 2013, American journal of physiology. Endocrinology and metabolism.

[9]  P. Conti,et al.  Fasting Enhances the Response of Glioma to Chemo- and Radiotherapy , 2012, PloS one.

[10]  F. Rossi Fanelli,et al.  Toxicity in chemotherapy--when less is more. , 2012, The New England journal of medicine.

[11]  Maurice B. Bizino,et al.  Food Cues Do Not Modulate the Neuroendocrine Response to a Prolonged Fast in Healthy Men , 2012, Neuroendocrinology.

[12]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[13]  D. Hardie,et al.  AMPK: a nutrient and energy sensor that maintains energy homeostasis , 2012, Nature Reviews Molecular Cell Biology.

[14]  Vito Pistoia,et al.  Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy , 2012, Science Translational Medicine.

[15]  C. Rübe,et al.  The impact of individual in vivo repair of DNA double-strand breaks on oral mucositis in adjuvant radiotherapy of head-and-neck cancer. , 2011, International journal of radiation oncology, biology, physics.

[16]  S. Vatner,et al.  Caloric restriction reduces growth of mammary tumors and metastases. , 2011, Carcinogenesis.

[17]  Changhan Lee,et al.  Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients , 2011, Oncogene.

[18]  P. Bastani,et al.  Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil) , 2011, Archives of Gynecology and Obstetrics.

[19]  T. Seyfried,et al.  Influence of Caloric Restriction on Constitutive Expression of NF-κB in an Experimental Mouse Astrocytoma , 2011, PloS one.

[20]  C. Parris,et al.  Prolonged expression of the γ-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment , 2011, International journal of cancer.

[21]  D. Sabatini,et al.  mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.

[22]  C. Rübe,et al.  DNA repair alterations in children with pediatric malignancies: novel opportunities to identify patients at risk for high-grade toxicities. , 2010, International journal of radiation oncology, biology, physics.

[23]  L. Partridge,et al.  Extending Healthy Life Span—From Yeast to Humans , 2010, Science.

[24]  T. Dorff,et al.  Fasting and cancer treatment in humans: A case series report , 2009, Aging.

[25]  Sterling C. Johnson,et al.  Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys , 2009, Science.

[26]  C. Redon,et al.  γ-H2AX as a biomarker of DNA damage induced by ionizing radiation in human peripheral blood lymphocytes and artificial skin. , 2009, Advances in space research : the official journal of the Committee on Space Research.

[27]  M. Löbrich,et al.  DNA Double-Strand Break Repair of Blood Lymphocytes and Normal Tissues Analysed in a Preclinical Mouse Model: Implications for Radiosensitivity Testing , 2008, Clinical Cancer Research.

[28]  L. Zitvogel,et al.  Immunogenic cancer cell death: a key-lock paradigm. , 2008, Current opinion in immunology.

[29]  S. Klein,et al.  Long‐term effects of calorie or protein restriction on serum IGF‐1 and IGFBP‐3 concentration in humans , 2008, Aging cell.

[30]  Changhan Lee,et al.  Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy , 2008, Proceedings of the National Academy of Sciences.

[31]  Linda J. Kuo,et al.  γ-H2AX - A Novel Biomarker for DNA Double-strand Breaks , 2008 .

[32]  W. Eiermann,et al.  Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[33]  L. Guarente,et al.  Genetic links between diet and lifespan: shared mechanisms from yeast to humans , 2007, Nature Reviews Genetics.

[34]  B. Bergman,et al.  Effects of fasting on insulin action and glucose kinetics in lean and obese men and women. , 2007, American journal of physiology. Endocrinology and metabolism.

[35]  P. Olive,et al.  Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  L. Tulman,et al.  Symptom Clusters: Concept Analysis and Clinical Implications for Cancer Nursing , 2005, Cancer nursing.

[37]  Matthias Egger,et al.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.

[38]  P. Olive,et al.  Phosphorylation of histone H2AX as a measure of radiosensitivity. , 2004, International journal of radiation oncology, biology, physics.

[39]  Stephen J Kron,et al.  Histone H2AX Phosphorylation as a Predictor of Radiosensitivity and Target for Radiotherapy* , 2004, Journal of Biological Chemistry.

[40]  Tim Byers,et al.  Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices , 2003, CA: a cancer journal for clinicians.

[41]  Howard L McLeod,et al.  Pharmacogenomics--drug disposition, drug targets, and side effects. , 2003, The New England journal of medicine.

[42]  Taber MacCallum,et al.  Calorie restriction in biosphere 2: alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[43]  S. Grottoli,et al.  Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency , 2001, International Journal of Obesity.

[44]  K. Matsumoto,et al.  High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal men. , 1996, The Journal of clinical endocrinology and metabolism.

[45]  A. Turturro,et al.  Age-Related Neoplasia in a Lifetime Study of Ad Libitum-Fed and Food-Restricted B6C3F1 Mice , 1995, Toxicologic pathology.

[46]  J. Ketelslegers,et al.  Nutritional regulation of the insulin-like growth factors. , 1994, Endocrine reviews.

[47]  V. Grill,et al.  Effects of dexamethasone on glucose-induced insulin and proinsulin release in low and high insulin responders. , 1990, Metabolism: clinical and experimental.

[48]  R. Weindruch,et al.  Dietary restriction in mice beginning at 1 year of age: effect on life-span and spontaneous cancer incidence. , 1982, Science.